Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.600
-0.040 (-2.44%)
Nov 21, 2024, 4:00 PM EST - Market closed
Chemomab Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 5.04 | 9.29 | 13.52 | 15.19 | 11.67 | 12.26 | Upgrade
|
| Short-Term Investments | 7.69 | 10.49 | 26.37 | 45.98 | 0.02 | - | Upgrade
|
| Cash & Short-Term Investments | 12.73 | 19.78 | 39.89 | 61.16 | 11.7 | 12.26 | Upgrade
|
| Cash Growth | -52.13% | -50.41% | -34.77% | 422.83% | -4.58% | 154.71% | Upgrade
|
| Other Receivables | 0.65 | 0.29 | 0.46 | 0.18 | 0.07 | 0.52 | Upgrade
|
| Receivables | 0.65 | 0.29 | 0.46 | 0.18 | 0.07 | 0.52 | Upgrade
|
| Prepaid Expenses | - | 0.75 | 1.31 | 1.35 | 0.07 | 0.03 | Upgrade
|
| Restricted Cash | 0.07 | 0.08 | 0.08 | - | - | - | Upgrade
|
| Total Current Assets | 13.46 | 20.9 | 41.74 | 62.69 | 11.84 | 12.8 | Upgrade
|
| Property, Plant & Equipment | 0.62 | 0.7 | 0.59 | 0.7 | 0.58 | 0.33 | Upgrade
|
| Other Long-Term Assets | 0.47 | 0.56 | 0.73 | 0.96 | 0.06 | 0.03 | Upgrade
|
| Total Assets | 14.54 | 22.15 | 43.06 | 64.35 | 12.48 | 13.16 | Upgrade
|
| Accounts Payable | 1.11 | 0.52 | 1.69 | 1.34 | 0.09 | 0.03 | Upgrade
|
| Accrued Expenses | 3.09 | 4.25 | 4.94 | 1.21 | 1.15 | 0.57 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.08 | 0.12 | 0.11 | 0.07 | 0.09 | Upgrade
|
| Total Current Liabilities | 4.31 | 4.84 | 6.75 | 2.65 | 1.32 | 0.68 | Upgrade
|
| Long-Term Leases | 0.25 | 0.32 | 0.09 | 0.24 | 0.36 | 0.11 | Upgrade
|
| Total Liabilities | 4.56 | 5.15 | 6.84 | 2.89 | 1.67 | 0.79 | Upgrade
|
| Additional Paid-In Capital | 106.16 | 105.68 | 101.26 | 97.64 | 34.5 | 0.9 | Upgrade
|
| Retained Earnings | -96.18 | -88.68 | -63.82 | -36.17 | -23.7 | -17.74 | Upgrade
|
| Treasury Stock | - | - | -1.22 | - | - | - | Upgrade
|
| Total Common Equity | 9.99 | 17 | 36.22 | 61.47 | 10.8 | -16.85 | Upgrade
|
| Shareholders' Equity | 9.99 | 17 | 36.22 | 61.47 | 10.8 | 12.37 | Upgrade
|
| Total Liabilities & Equity | 14.54 | 22.15 | 43.06 | 64.35 | 12.48 | 13.16 | Upgrade
|
| Total Debt | 0.36 | 0.39 | 0.21 | 0.34 | 0.43 | 0.2 | Upgrade
|
| Net Cash (Debt) | 12.37 | 19.39 | 39.68 | 60.82 | 11.27 | 12.06 | Upgrade
|
| Net Cash Growth | -53.24% | -51.13% | -34.76% | 439.65% | -6.58% | 150.65% | Upgrade
|
| Net Cash Per Share | 0.93 | 1.65 | 3.49 | 5.86 | 1.65 | - | Upgrade
|
| Filing Date Shares Outstanding | 14.36 | 14.2 | 11.05 | 11.4 | - | - | Upgrade
|
| Total Common Shares Outstanding | 14.36 | 14.2 | 11.05 | 11.4 | - | - | Upgrade
|
| Working Capital | 9.15 | 16.06 | 34.99 | 60.04 | 10.52 | 12.12 | Upgrade
|
| Book Value Per Share | 0.70 | 1.20 | 3.28 | 5.39 | - | - | Upgrade
|
| Tangible Book Value | 9.99 | 17 | 36.22 | 61.47 | 10.8 | -16.85 | Upgrade
|
| Tangible Book Value Per Share | 0.70 | 1.20 | 3.28 | 5.39 | - | - | Upgrade
|
| Machinery | - | 0.5 | 0.5 | 0.43 | 0.21 | 0.18 | Upgrade
|
| Leasehold Improvements | - | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.